Lineage Cell Therapeutics dismisses Withum, appoints Moss Adams as auditor

Lineage Cell Therapeutics, Inc.

Audit committee dismissed WithumSmith+Brown effective June 11, 2024.
Engaged Moss Adams as independent auditor for fiscal year ending Dec 31, 2024.
No disagreements or reportable events with former auditor in past two years.

item 4.01 item 9.01

Lineage Cell Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-073769

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.